Online citations, reference lists, and bibliographies.

Validation That Metabolic Tumor Volume Predicts Outcome In Head-and-neck Cancer.

Chad Tang, James D Murphy, Brian Khong, Trang H. La, Christina S. Kong, Nancy Fischbein, Alexander Dimitrios Colevas, Andrei Iagaru, Edward E Graves, Billy W. Loo, Quynh-Thu Le
Published 2012 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
PURPOSE We have previously reported that metabolic tumor volume (MTV) obtained from pretreatment (18)F-fluorodeoxydeglucose positron emission tomography (FDG PET)/ computed tomography (CT) predicted outcome in patients with head-and-neck cancer (HNC). The purpose of this study was to validate these results on an independent dataset, determine whether the primary tumor or nodal MTV drives this correlation, and explore the interaction with p16(INK4a) status as a surrogate marker for human papillomavirus (HPV). METHODS AND MATERIALS The validation dataset in this study included 83 patients with squamous cell HNC who had a FDG PET/CT scan before receiving definitive radiotherapy. MTV and maximum standardized uptake value (SUV(max)) were calculated for the primary tumor, the involved nodes, and the combination of both. The primary endpoint was to validate that MTV predicted progression-free survival and overall survival. Secondary analyses included determining the prognostic utility of primary tumor vs. nodal MTV. RESULTS Similarly to our prior findings, an increase in total MTV of 17 cm(3) (difference between the 75th and 25th percentiles) was associated with a 2.1-fold increase in the risk of disease progression (p = 0.0002) and a 2.0-fold increase in the risk of death (p = 0.0048). SUV(max) was not associated with either outcome. Primary tumor MTV predicted progression-free (hazard ratio [HR] = 1.94; p < 0.0001) and overall (HR = 1.57; p < 0.0001) survival, whereas nodal MTV did not. In addition, MTV predicted progression-free (HR = 4.23; p < 0.0001) and overall (HR = 3.21; p = 0.0029) survival in patients with p16(INK4a)-positive oropharyngeal cancer. CONCLUSIONS This study validates our previous findings that MTV independently predicts outcomes in HNC. MTV should be considered as a potential risk-stratifying biomarker in future studies of HNC.
This paper references
Human papillomavirus and survival of patients with oropharyngeal cancer.
K Kian Ang (2010)
Intensity-modulated radiotherapy for locally advanced cancers of the larynx and hypopharynx.
Megan E. Daly (2011)
Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
Jean-Pierre Pignon (2009)
HPV-associated head and neck cancer: a virus-related cancer epidemic.
Shanthi Marur (2010)
Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen.
Jean-François Daisne (2004)
Platelet and endothelial adhesion on fluorosurfactant polymers designed for vascular graft modification.
Chad Tang (2009)
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
R. Gray (1988)
Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma.
Malik E Juweid (2007)
Prognostic value of 18F-FDG PET-CT metabolic index for nasopharyngeal carcinoma
Peng Xie (2009)
Intensity-modulated radiotherapy in the treatment of oropharyngeal cancer: clinical outcomes and patterns of failure.
Megan E. Daly (2010)
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer.
Trang H. La (2009)
Prospective risk-adjusted [18F]Fluorodeoxyglucose positron emission tomography and computed tomography assessment of radiation response in head and neck cancer.
Benjamin J. Moeller (2009)
Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial.
Danny Rischin (2010)
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas.
Christina S. Kong (2009)
Postradiation metabolic tumor volume predicts outcome in head-and-neck cancer.
James D Murphy (2011)
Impact of fdg-pet/ct fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma: intermethod and interobserver variations
Ryuji Murakami (2008)

This paper is referenced by
PET/CT in radiotherapy planning in head and neck cancers
Ana María García Vicente (2015)
Role of pretreatment fluorodeoxyglucose positron emission tomography quantitative parameters in prognostication of head-and-neck squamous cell carcinoma
Narayana Subramaniam (2019)
The Application of FDG-PET as Prognostic Indicators in Head and Neck Squamous Cell Carcinoma.
Farzan Siddiqui (2012)
Metabolic tumour volume as a prognostic factor for oral cavity squamous cell carcinoma treated with primary surgery
Han Zhang (2014)
Correlation between the malignancy and prognosis of oral squamous cell carcinoma in the maximum standardized uptake value
On Hasegawa (2018)
Positron Emission Tomography (PET) Tumor Segmentation and Quantification: Development of New Algorithms
Ruchir N. Bhatt (2012)
Prognostic value of volumetric parameters measured by 18F-FDG PET/CT in patients with head and neck squamous cell carcinoma
Ronan Abgral (2013)
Organ Preservation Protocols in T4 Laryngeal Cancer: a Review of the Literature
Narayana Subramaniam (2018)
Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma.
Krishna C Alluri (2014)
Prognostic significance and predictive performance of volume-based parameters of F-18 FDG PET/CT in squamous cell head and neck cancers.
Sait Sağer (2014)
Pre-treatment tumor-specific growth rate as a temporal biomarker that predicts treatment failure and improves risk stratification for oropharyngeal cancer.
Colin T. Murphy (2015)
Prognostic value of 18F-fluorodeoxyglucose-positron emission tomography/computed tomography scan volumetric parameters in head-and-neck cancer patients after treatment
Mehrdad Bakhshyesh Karam (2018)
Refining risk stratification for locoregional failure after chemoradiotherapy in human papillomavirus-associated oropharyngeal cancer.
Jeffrey M. Vainshtein (2014)
Predictive Values of MRI and PET Derived Quantitative Parameters for Patterns of Failure in Both p16+ and p16– High Risk Head and Neck Cancer
Yue Cao (2019)
Clinical Utility of Pretreatment and 3-Month 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Standardized Uptake Value in Predicting and Assessing Recurrence in T3-T4 Laryngeal Carcinoma Treated With Definitive Radiation
Zachary Mayo (2019)
PET/CT imaging-guided dose painting in radiation therapy.
Xiaorong Shi (2014)
Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation
Shu-Hang Ng (2016)
Radiotherapy treatment planning based on functional PET/CT imaging data
Daniela Thorwarth (2012)
Radiothérapie adaptative morphologique et métabolique des cancers ORL
Joël Castelli (2017)
Application of fluorodeoxyglucose positron emission tomography in the management of head and neck cancers.
Farzan Siddiqui (2014)
Oesophagogastric cancer: exploring the way to an individual approach
Jurriën Stiekema (2015)
Head and neck squamous cell cancer (stages III and IV) induction chemotherapy assessment: value of FDG volumetric imaging parameters.
Jielin Yu (2014)
The prognostic role of 18F-fluorodeoxyglucose PET in head and neck cancer depends on HPV status.
Jon M Moan (2019)
FDG-PET metabolic tumor parameters for the reirradiation of recurrent head and neck cancer.
Maria Agudelo Velez (2018)
The evolving role of positron emission tomography-computed tomography in organ-preserving treatment of head and neck cancer.
Madhur Garg (2012)
Prognostic value of pretreatment 18F-fluorodeoxyglucose positron emission tomography/CT volume-based parameters in patients with oropharyngeal squamous cell carcinoma with known p16 and p53 status.
Masahiro Kikuchi (2015)
Prognostic effects of the metabolic tumor volume and total lesion glycolysis in patients with advanced squamous cell carcinoma of head and neck
He-Yuan Hsieh (2018)
Imaging of head and neck cancers
Taha S. Meraj (2016)
Integrating Tumor and Nodal Imaging Characteristics at Baseline and Mid-Treatment Computed Tomography Scans to Predict Distant Metastasis in Oropharyngeal Cancer Treated With Concurrent Chemoradiotherapy.
Jia Wu (2019)
Role of Pre -Treatment FDG PET Quantitative Parameters in Prognostication of Head and Neck Squamous Cell Carcinoma-A Review
Narayana Subramaniam (2017)
FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.
Vasavi Paidpally (2012)
Head and Neck Squamous Cell Cancer
Carsten Nieder (2013)
See more
Semantic Scholar Logo Some data provided by SemanticScholar